Boehringer Ingelheim has inaugurated a biomass power plant at its Ingelheim facility, aiming to achieve significant reductions in carbon emissions.
According to Michael Schmelmer, Vice Chairman of the Board of Managing Directors, the plant represents a “significant milestone” in their sustainability goals. He stated, “Part of our sustainability goals is to protect natural resources so that our earth remains a place worth living in for people and animals.
With an environmentally friendly and more independent energy supply, we are ensuring stable production in order to be able to deliver medications for patients worldwide.”
The new biomass facility is expected to cut approximately 50,000 tons of CO2 emissions annually, contributing to a 70% reduction in the site’s own energy generation footprint.
Boehringer Ingelheim has committed €205 million to sustainable infrastructure projects at the site, aiming to cover 95% of its energy requirements from renewable sources in the future.
The ceremonial inauguration was attended by German Vice Chancellor and Federal Minister of Economics Robert Habeck and Rhineland-Palatinate Environment Minister Katrin Eder. Habeck praised Boehringer Ingelheim as a model for decarbonisation efforts, stating, “The company uses renewable energies for production. It trains and attracts talents as an attractive employer. Last but not least, it invests heavily in research and development, thus contributing to better healthcare and future proofing of the site.”
